Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) ...
Company positions itself as the central research hub for patients, clinicians, and compounding pharmacies tracking the ...
FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.
Michigan Governor Gretchen Whitmer condemned the 5th Circuit Court of Appeals ruling that blocks doctors nationwide from ...
The FDA accepted an NDA for a bictegravir and lenacapavir single-tablet regimen for adults with HIV-1 who have achieved virologic suppression.
The FDA has approved Saphnelo (anifrolumab-fnia) for subcutaneous administration in patients with systemic lupus ...
The Senate bill proposes to open a limited psychedelic-assisted therapy pilot program established in 2022 to people who are ...
A data monitoring committee recommended stopping FLASH2, a randomized double-blind placebo-controlled confirmatory phase 3 ...
The Centers for Disease Control and Prevention is warning the public about drug-resistant salmonella infections after at ...
On International Workers' Day, labor rights and U.S. charges against Sinaloa's governor took center stage at Sheinbaum's ...
An overhaul to a federal drug discount program Indiana officials allege is being misused by hospitals to generate profits ...
The execution Thursday of James Hitchcock was the sixth so far in Florida this year, a stunning pace that has Florida leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results